http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2002081503-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0202 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 |
| filingDate | 2001-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2002081503-A1 |
| titleOfInvention | Novel K97-0239 substance and production method thereof |
| abstract | The following formula [I] A K97-0239A substance represented by the following formula [II]: A microorganism having the ability to produce the K97-0239 substance consisting of the K97-0239B substance represented by is cultured in a medium, the K97-0239 substance is accumulated in the culture, and the K97-0239 substance is collected from the culture. I do. Since the obtained substance has low toxicity and specifically inhibits macrophage foaming, it is useful for prevention and treatment of human arteriosclerosis and diseases caused thereby. |
| priorityDate | 2001-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.